Mersana Therapeutics logo
Mersana Therapeutics MRSN
$ 2.05 3.54%

Quarterly report 2024-Q3
added 11-13-2024

report update icon

Mersana Therapeutics EV/EBITDA Ratio 2011-2024 | MRSN

Annual EV/EBITDA Ratio Mersana Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
221 -12.1 -8.5 -0.712 -3.98 - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
221 -12.1 39.1